Agenda for 6 December TC meeting

4 December 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for 22 November TC meeting

22 November 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for 9 November TC meeting

7 November 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

European Medicines Agency staff could live in London and commute to France after Brexit

23 October 2017 - EU scientists could be allowed to live with their families in London and commute to the ...

Read more →

Agenda for 25 October TC meeting

20 October 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for 11 October TC meeting

9 October 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for 27 September TC meeting

25 September 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for 13 September TC meeting

8 September 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for 19 July TC meeting

15 July 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

HAS publishes TC opinion on Olumiant

6 July 2017 - The medical service rendered by Olumiant (baricitinib) is important. ...

Read more →

Transparency Commission publishes opinion for Keytruda

20 June 2017 - The opinion relates to the use of pembrolizumab for the first-line use in patients with non-small-cell ...

Read more →

Agenda for 21 June TC meeting

16 June 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Agenda for 7 June 2017 TC meeting

2 June 2017 - HAS has posted the agenda for the next scheduled TC meeting. ...

Read more →

Transparency Commission revises ASMR for Imbruvica

1 June 2017 - The Transparency Commission has published its revised opinion on the ASMR for ibrutinib for patients with ...

Read more →

Transparency Commission publishes its review of Keytruda's SMR & ASMR

22 May 2017 - The Transparency Commission has reviewed its SMR & ASMR ratings of pembrolizumab for malignant melanoma. ...

Read more →